Ethical Challenges of HIV Clinical Trials in Developing Countries
Bioethics. 1998 Oct; 12(4): 320-327.
Aids; Alternative Therapies; Autonomy; Beneficence; Clinical Trials; Control Groups; Developing Countries; Drug Industry; Drugs; Economics; Ethical Review; Guidelines; Health; HIV Seropositivity; Human Experimentation; Human Rights; Industry; International Aspects; Investigators; Justice; Medicine; Moral Policy; Newborns; Non-Western World; Organizations; Placebos; Pregnant Women; Preventive Medicine; Public Policy; Research; Research Design; Research Subjects; Review; Rights; Standards; Therapeutic Research; Western World;
Showing items related by title, author, creator and subject.
The Conduct of Clinical Trials of Maternal-Infant Transmission of HIV Supported by the United States Department of Health in Developing Countries: A Summary of the Needs of Developing Countries, the Scientific Applications, and the Ethical Considerations Assessed by the National Institutes of Health and the Centers for Disease Control and Prevention 1994-1997 Includes as an Appendix: Recommendations From the Meeting on Mother-to-Infant Transmission of HIV by Use of Antiretrovirals, Geneva 23-25 June 1994 Unknown creator (United States. Department of Health and Human Services, 1997-07)
The promise and pitfalls of clinical trials overseas. Big pharma has big incentives, including cost savings and more powerful studies, to launch trials in developing countries. But can companies avoid the ethical potholes? Bagla, Pallava; Normile, Dennis; Xi, Chen (2008-10-10)